Intensified and Continuous Upstream (USP) Processing

Future-proof your manufacturing strategies, reduce costs and increase facility flexibility with intensified fed-batch and perfusion processes

HomeIntegrated OfferingsBiopharma 4.0Intensified and Continuous Upstream (USP) Processing


Make the best decisions to increase productivity, reduce costs, improve facility flexibility, and future-proof manufacturing strategies by intensifying your upstream process.

Biopharmaceutical developers and manufacturers need efficient, productive upstream processes that deliver high-quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification, including intensified fed-batch and perfusion processes, offers many options to future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.

With a full suite of solutions designed to support the increased demands of intensified upstream processes and technical support from teams with years of experience, we can support you in choosing the best strategies to realize the benefits of upstream process intensification without compromising clinical milestones or speed to market.

Intensified and Continuous Upstream (USP) Processing

Today’s biopharmaceutical manufacturers are confronted with numerous challenges:

  • Speed-to-market and cost-efficient production for competitive advantage 
  • Flexibility to increase throughput or target a smaller patient population 
  • Agility to process multiple products in a single facility 
  • High volumetric productivity  with a smaller facility footprint

Upstream process intensification, as a cornerstone of this transformation, can deliver new gains in efficiency while sustaining or improving product quality. Innovative approaches are needed to address these challenges and future-proof manufacturing strategies for the facility of the future. We have developed several upstream intensification strategies for seed train and production and harvest processes, including high cell density cryopreservation and perfusion solutions. Whether you’re developing an intensified fed-batch or perfusion process, our integrated solutions enable you to increase volumetric productivity which can translate into higher throughput, improved facility utilization and flexibility, compressed timelines, and reduced manufacturing and capital costs. With technical support from a global team with extensive application and regulatory expertise we empower you to take the right decisions faster.

Related Categories

A scientist works on a bioreactor while sitting at a white counter next to a window.
Cell Retention

Perfusion operations deliver high-density cell cultures that alleviate the burden of processing large production bioreactor...

The Mobius® Single-Use Bioreactor family of products can be seen.
Bioprocessing Mobius® Single-Use Bioreactors

Mobius® products and solutions can help you meet your evolving cell culture needs...

Bioprocessing Cell Culture Media
Bioprocessing Cell Culture Media

With our comprehensive portfolio, you can choose from tried-and-true formulations...

Mobius® 3D Bag Assembly in 3D Large Liquid Transport Bin
Single-Use Assemblies

Streamline biopharma manufacturing with Mobius® 2D and 3D single-use assemblies.

A scientists looks at a sample on a microscope.
Bioprocessing Cell Lines

A cell line that maintains favorable growth and productivity is vital for mab manufacturing.

Related Resources

Page 1 of 3

Related Webinars

Implementing High Cell Density Cryopreservation in Your Intensified Seed Train

Explore the use and benefits of a high cell density cryopreservation (HCDC)

Enabling Upstream Intensified Bioprocessing

Intensified upstream bioprocesses are being developed to increase productivity while...

A Cost Analysis and Evaluation of Perfused Seed Train Scenarios Through Process Modeling

Learn how perfused seed train options could deliver lower cost of goods, increase product throughput, or a combination of both.

Cold Hard Facts: Implementing High Cell Density Cryopreservation in your Intensified Seed Train

The integration of a perfused N-1 step in upstream process is highlighted to either decrease facility footprint or to be able to inoculate final fed-batch N-stage with a higher cell density as a conventional fed-batch.

Media and Process Development for Seed Train Intensification

Media composition plays a critical role for biopharmaceutical production as well as seed train expansion.

The BioContinuum™ Seed Train Platform

Upstream process intensification can bring significant benefits to manufacturers in terms of smaller facilities, manufacturing flexibility, and reduction in footprint, with achieving significantly higher productivity.

Related Videos

BioContinuum™ Platform: Your enabler of the biomanufacturing facility of the future!

Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?